China’s top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19. Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration. The approval clears the way for the …